News
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
52m
Investor's Business Daily on MSNDow Jones Hits Record High On Dovish Powell After AI Worries, Walmart Woes: Weekly Review
The Dow Jones and S&P 500 jumped Friday to record highs on Fed chief Jerome Powell's dovish Jackson Hole speech.
Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...
Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results